NewsRoom Articles - Page 32 of 154 - PsychedelicNewsWire (PNW)

MondayMay 08, 2023 3:38 pm

Study Looks into Neurobiology of Psychedelics

Since the late 19th century, physicians have used laughing gas as an anesthetic. Laughing gas, or nitrous oxide as it is scientifically known as, was first discovered by Joseph Priestly, an English scientist in 1793. This colorless, odorless and nonflammable gas is known to produce mind-altering experiences when administered in small amounts, similar to states induced by psychedelics such as ketamine and LSD. New research has looked into how nitrous oxide affects brain activity and how similar its effects are to those of psychedelics. The study was led by Richard Harris and George Mashour of the Michigan Psychedelic Center at…

FridayMay 05, 2023 12:44 pm

New Collaboration Makes Brain Scanning Technology Available for Psychedelics Trials

Clerkenwell Health, a psychedelic-specialist clinical research firm, recently partnered with MYndspan, which will give medical researchers access to magnetoencephalography (MEG) scanners. MYndspan is a brain analytics firm that allows users to evaluate and monitor brain health to extend the healthy lifespan of the mind. This may be the first time MEG brain scanning technology has been availed for use in commercial clinical trials at Clerkenwell Health’s facility in central London. Clerkenwell Health has been carrying out clinical trials on psychedelics since last autumn to support the development of pharmaceuticals. Psychedelics are known to alter neural networks in the human brain,…

ThursdayMay 04, 2023 1:57 pm

Challenges That May Make Psychedelic Therapies Unaffordable

Earlier this year, Australia became the first country globally to legalize the medical use of psychedelics. This comes after the country’s Therapeutic Goods Administration approved the use of MDMA and psilocybin by individuals with eligible mental health conditions. This agency reclassified psilocybin as well as MDMA as Schedule 8 substances, prior to which they were considered prohibited substances. Beginning July 1, 2023, authorized practitioners will be allowed to prescribe psilocybin for treatment-resistant depression and MDMA for PTSD, together with psychotherapy. Despite this huge step forward, however, there are still issues to resolve before this can benefit those who need it…

WednesdayMay 03, 2023 3:03 pm

Video Series Explores Psychedelics, Boundaries of Society

A recent study has found combining psychedelics and sex may offer individuals an enhanced mental and physical pleasure experience. A new series, titled “PSYC Taboo,” will explore the potential for mind-blowing orgasms and solo psychedelic experiences, as more people try alternative forms of intimacy. The first episode, dubbed “Pleasure Is Your Divine Right,” looks into the relationship between psychedelics and sex. Despite the taboo topic, the pilot examines testimonies and personal experiences from an individual living with type 1 diabetes, who shares how psychedelics improved their sexual life and introduced them to new pleasure levels. Esteemed experts such as Dr.…

TuesdayMay 02, 2023 1:41 pm

Colorado Senate Approves Measure Regulating Psychedelics

Last week, the Colorado Senate approved a measure that would establish a regulatory framework for legal psychedelics. The regulations will mainly focus on how the drugs will be administered in licensed healing facilities under the guidance of trained facilitators. Individuals aged 21 years and above are eligible for psychedelic treatment. The legislation will also set up licensing requirements as well as rules for cultivation, dictate the responsibilities of the line agencies and establish penalties for illegal activities. Prior to its passing, the resolution was cleared by the Appropriations Committee and the Senate Finance Committee. It has now been advanced to…

MondayMay 01, 2023 2:30 pm

AI in Psychedelic Space Projected to Grow

Numerous studies have shown that psychedelics possess a range of therapeutic benefits that may be useful in treating various conditions. For instance, one study found that administering psilocybin reduced anxiety and depression in patients with cancer. This research also intersects with artificial intelligence (“AI”), as companies involved in the space work toward ensuring therapy centers are safe places to provide psychedelic therapy. The use of artificial intelligence is expected to increase in this field as companies accelerate their research and realize their visions using this technology. Sam Altman, the creator of ChatGPT, is also the chairman of Journey Colab, a…

FridayApr 28, 2023 2:22 pm

Challenges Facing European Psychedelics Industry

Psychedelics are hallucinogenic drugs that induce temporary alterations in mood, perception and mental processes in an individual when ingested. These drugs can occur naturally, such as psilocybin, or be manufactured in a lab, such as LSD, which was first synthesized by Albert Hoffman in 1938. Before psychedelics were classified under Schedule 1 of the 1971 UN Convention on Psychotropic Drugs, the drugs were used to manage various symptoms and psychiatric issues. This classification was brought on mainly by the growing hostility of sociopolitical views regarding the use of drugs as well as the covert and unethical use of said drugs.…

ThursdayApr 27, 2023 2:45 pm

Oregon Officials Announce Approval of First Testing Lab for Psilocybin

Regulators in Oregon recently announced that they have approved a licensed testing lab for psilocybin, the first of its kind in the country. The Oregon Health Authority revealed that the license would be awarded to Rose City Labs. In a press release, Angie Allbee of Oregon Psilocybin Services stated that lab testing ensured correct labeling of the drug’s potency as well as the safety of products. The announcement comes after the Oregon Health Authority granted permission to licensed practitioners to give psilocybin to adults at certain facilities. Officials were responsible for issuance of licenses to manufacture, test and administer psilocybin…

WednesdayApr 26, 2023 11:55 am

New E60 Episode Looks into Psychedelics as Mental Health Treatment for Athletes

The latest episode on ESPN E60 looks at the use of psychedelics in treating mental health conditions for athletes. The episode, titled Peace of Mind, debuted on April 22, 2023, and was directed and produced by Blake Foeman. The segment focuses on sports, healing and the use of alternative medicines, featuring former Canadian professional ice hockey player, Riley Cote, who has been vocal about the benefits of psychedelics. Cote, who was with the Philadelphia Flyers at the time, scored his only goal against the Montreal Canadiens in February 2008. However, he was involved in many physical altercations during games, which…

TuesdayApr 25, 2023 12:26 pm

The US May Soon Approve MDMA Therapy for PTSD Treatment

This year, the U.S. government will decide whether to approve the use of psychedelic drugs such as MDMA for the treatment of a range of mental health conditions. This milestone will not only be significant for patients in need of alternative therapies but also major players in the industry, including the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a nonprofit organization that specializes in research and education on psychedelics. It was founded in 1986 by Rick Doblin, who has spent decades studying whether psychedelics — MDMD in particular — could help treat patients suffering from post-traumatic stress disorder. MDMA, which…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000